MangoRx to Introduce Oral Semaglutide and Tirzepatide in Response to Increasing Patient Demand for GLP-1 Medications
GlobeNewswire
Formulations to be marketed as “Slim” and “Trim” as an Oral Dissolvable Tablet (ODT)
*Dallas, TX, May 21, 2024..